Skip to main content
. 2017 Mar 15;8(13):22076–22085. doi: 10.18632/oncotarget.16195

Figure 2. Correlation analysis between serum 25(OH)D and inflammation in patients with prostate cancer and controls.

Figure 2

(A) Correlation analysis between serum 25(OH)D and CRP in control subjects. (B) Correlation analysis between serum 25(OH)D and CRP in patients with prostate cancer. (C) Correlation analysis between serum 25(OH)D and IL-8 in control subjects. (D) Correlation analysis between serum 25(OH)D and IL-8 in patients with prostate cancer.